Adult Vaccination Strategies

This latest exploration of adult vaccination strategies underscores the crucial role of life-course immunisation in safeguarding health at every stage of life, especially as populations age. The findings emphasize that prioritizing adult immunisation can prevent diseases that significantly impact older adults and other at-risk groups, with respiratory infections remaining a critical focus post-COVID-19. Through a preventive approach, these strategies promise to reduce health burdens and create broader economic benefits for individuals and society. Economic insights from this report reveal that adult immunisation not only cuts healthcare costs by reducing severe cases and hospitalisations but also boosts productivity and eases pressure on healthcare systems. Examples like Spain’s pioneering use of a monoclonal antibody against respiratory syncytial virus (RSV) in children highlight the impact of targeted vaccination. With dedicated vaccine budgets and digital tools to enhance access, these strategies lay the groundwork for a resilient healthcare model that prioritises prevention for lasting benefits across Europe.